Recombinant CD138 (Indatuximab Biosimilar) antibody
The Chimeric Chimeric anti-CD138 (Indatuximab Biosimilar) antibody is suitable to detect CD138 (Indatuximab Biosimilar) in samples from Human.
Catalog No. ABIN7597747
-15% Promotion 2026
$340.97
save $60.17 (-15 %)
Plus shipping costs $50.00, if applicable $20.00 dry ice
Shipping to:
United States
Delivery in 12 to 14 Business Days
Quick Overview for Recombinant CD138 (Indatuximab Biosimilar) antibody (ABIN7597747)
Target
CD138 (Indatuximab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Chimeric
Clonality
Chimeric
Conjugate
This CD138 (Indatuximab Biosimilar) antibody is un-conjugated
Application
Please inquire
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Research Grade Indatuximab Biosimilar Antibody
-
Specificity
- CD138, SDC1, SDC, Syndecan-1, SYND1
-
Purification
- Protein A or G purified from cell culture supernatant.
-
Purity
- >95 % by SDS-PAGE.
-
Isotype
- IgG4 kappa
-
-
anti-CD138 (Indatuximab Biosimilar) antibody
Research Grade Reactivity: Human FACS Host: Mouse Chimeric unconjugated Recombinant Antibody
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4.
-
Storage
- 4 °C,-20 °C,-80 °C
-
Storage Comment
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
-
Expiry Date
- 12 months
-
-
- CD138 (Indatuximab Biosimilar)
-
Alternative Name
- Indatuximab Biosimilar
-
Target Type
- Biosimilar
-
Background
- CD138, SDC1, SDC, Syndecan-1, SYND1
-
UniProt
- P18827
Target
-
You are here:
